What a wonderful way to end the year! Accord Healthcare is a Category Award Winner in four areas in the 2023 Pharmaceutical-Technology Excellence Awards – Business Expansion, Product Launches, Research and Development, and Social Impact. These accolades are a testament to our unwavering dedication and innovative approach across the categories.
Research and Development: Our commitment to groundbreaking research in biologics has led to the establishment of a new, advanced laboratory in London, further strengthening our research and development capabilities.
Product Launches: This year, we've continued our focus on the oncology sector. While adhering to the highest standards of compliance and ethical practice, we've made strides in providing supportive care and options in this crucial area of medicine.
Business Expansion: Accord’s Business Development team has significantly enhanced our market presence through strategic partnerships and resource optimisation. Our strategy has been instrumental in expanding access to vital medicines across Europe, with an ambitious roadmap for launching new products that will continue to enhance patient care.
Social Impact: Our combined efforts in 'Project Hope' and other initiatives have made a significant impact, providing essential medical assistance and humanitarian aid, notably in Ukraine, demonstrating our commitment to global health and social responsibility.
We're immensely proud of these recognitions and remain dedicated to enhancing health and making it better around the world. #makeitbetter
